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Abstract
Purpose: n-3 fatty acids are known to exert  multiple  beneficial effects including anti-inflammatory actions  that 
may diminish oxidative stress. Supplementation with antioxidant vitamins has been proposed to counteract 
oxidative stress and improve antioxidant status. Therefore, this project investigated the effects of daily 
supplementation in 48 trained cyclists over 6 wk and during 3 d of continuous exercise on F2-isoprostanes 
(oxidative stress), plasma n-3 fatty acids, and antioxidant status (oxygen radical absorption capacity and ferric-
reducing antioxidant potential). Methods: Cyclists  were  randomized  into  n-3  fatty  acids (N3) (n = 11) (2000 
mg of eicosapentaenoic acid and 400 mg of docosahexaenoic acid), a vitamin–mineral (VM) complex (n = 12) 
emphasizing vitamins C (2000 mg), E (800 IU), A (3000 IU), and selenium (200 Kg), a VM and n-3 fatty acid 
combination (VN3)    (n = 13), or placebo (P) (n = 12). Blood was collected at baseline and preexercise and 
postexercise. A 4 x 3 repeated-measures ANOVA was performed to test main effects. Results: After exercise, F2-
isoprostanes were higher in N3 (treatment effect P = 0.014). Eicosapentaenoic acid and docosahexaenoic acid 
plasma values were higher after supplementation (interaction effect P = 0.001 and 0.006, respectively) in both 
n-3 supplemented groups. Oxygen radical absorption capacity declined similarly among all groups      after
exercise. Ferric-reducing antioxidant potential exhibited significant interaction (P = 0.045) and significantly
increased after exercise in VN3 and VM (P G 0.01). Conclusions: This study indicates that supplementation with n-3
fatty acids alone significantly increases F2-isoprostanes after exhaustive exercise. Lastly, antioxidant
supplementation augments plasma antioxidant status and modestly attenuates  but  does  not  prevent  the
significant  n-3  fatty  acid  associated  increase  in  F2-isoprostanes  postexercise.
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ABSTRACT
MCANULTY, S. R., D. C. NIEMAN, M. FOX-RABINOVICH, V. DURAN, L. S. MCANULTY, D. A. HENSON, F. JIN, and M. J.
LANDRAM. Effect of n-3 Fatty Acids and Antioxidants on Oxidative Stress after Exercise. Med. Sci. Sports Exerc., Vol. 42, No. 9,
pp. 1704–1711, 2010. Purpose: n-3 fatty acids are known to exert multiple beneficial effects including anti-inflammatory actions
that may diminish oxidative stress. Supplementation with antioxidant vitamins has been proposed to counteract oxidative stress and
improve antioxidant status. Therefore, this project investigated the effects of daily supplementation in 48 trained cyclists over 6 wk
and during 3 d of continuous exercise on F2-isoprostanes (oxidative stress), plasma n-3 fatty acids, and antioxidant status (oxygen
radical absorption capacity and ferric-reducing antioxidant potential). Methods: Cyclists were randomized into n-3 fatty acids
(N3) (n = 11) (2000 mg of eicosapentaenoic acid and 400 mg of docosahexaenoic acid), a vitamin–mineral (VM) complex (n = 12)
emphasizing vitamins C (2000 mg), E (800 IU), A (3000 IU), and selenium (200 Kg), a VM and n-3 fatty acid combination (VN3)
(n = 13), or placebo (P) (n = 12). Blood was collected at baseline and preexercise and postexercise. A 4  3 repeated-measures
ANOVA was performed to test main effects. Results: After exercise, F2-isoprostanes were higher in N3 (treatment effect P = 0.014).
Eicosapentaenoic acid and docosahexaenoic acid plasma values were higher after supplementation (interaction effect P = 0.001 and
0.006, respectively) in both n-3 supplemented groups. Oxygen radical absorption capacity declined similarly among all groups
after exercise. Ferric-reducing antioxidant potential exhibited significant interaction (P = 0.045) and significantly increased after
exercise in VN3 and VM (P G 0.01). Conclusions: This study indicates that supplementation with n-3 fatty acids alone significantly
increases F2-isoprostanes after exhaustive exercise. Lastly, antioxidant supplementation augments plasma antioxidant status and
modestly attenuates but does not prevent the significant n-3 fatty acid associated increase in F2-isoprostanes postexercise.
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O
mega-3 fatty acids (n-3fa) comprise a family of
unsaturated fatty acids that consist of >-linolenic
acid, eicosapentaenoic acid (EPA), and docosa-
hexaenoic acid (DHA), which are essential nutrients that
must be obtained from food because of the inability of
humans to synthesize these fatty acids de novo (28). Human
beings evolved consuming a diet that contained about equal
amounts of omega-6 (n-6fa) and n-3fa fatty acids. Current
western diets provide ratios of n-6fa to n-3fa ranging from
approximately 10:1 to 20:1 instead of the traditional range
of 1:1 to 2:1, respectively. It is known that a high intake of
n-6fa increases prothrombotic and proaggregatory activities
characterized by increases in blood viscosity and vasospasm
and vasoconstriction (27). Given that n-3fa exhibit anti-
inflammatory, antithrombotic, antiarrhythmic, hypolipide-
mic, and vasodilatory properties, an increased consumption
of n-3fa would likely be beneficial (27).
Although n-3fa have potential benefits against certain
diseases such as cardiovascular disease, Alzheimer’s dis-
ease, Parkinson’s disease, diabetes mellitus, essential hyper-
tension, and atherosclerosis, questions remain about the
effect on subsequent oxidative stress if supplemented alone
or in conjunction with other antioxidants (4,8,15,26).
Specifically, increased consumption of n-3fa may lead to
increased lipid peroxidation (18). Thus far, the data
obtained in vivo are not conclusive for (18) or against (1)
increased lipid peroxidation with n-3 fatty acid supplemen-
tation. Furthermore, a study that has examined n-3fa sup-
plementation and oxidative damage with exercise has not
been conducted to our knowledge. Therefore, it is not
known whether heavily exercising athletes should supple-
ment with n-3fa.
It is well established that a causal link exits between
oxidative stress and various disease states such as cancer and
heart disease (2,7). Routine exercise is generally regarded as
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being beneficial and helpful in disease and mortality pre-
vention (5). Somewhat paradoxical is the fact that acute
exercise results in an increase in oxidative damage (17), but
chronic exercise is known to be anti-inflammatory and re-
duces the amount of damage that occurs during acute exer-
cise (12). Because an excess of oxidative stress is associated
with negative consequences, supplementation with antioxi-
dant vitamins has been proposed to counteract oxidative
stress and to improve antioxidant status, but the existing
literature is equivocal regarding exercise and antioxidant
vitamins (16,17). Interestingly, Ristow et al. (25) found that
supplementation with antioxidant vitamins actually amelio-
rated beneficial adaptations from exercise in preventing in-
sulin resistance. Previous antioxidant research by our team
indicates that individual antioxidants, even in high doses,
are not effective at preventing peroxidation (17,23), but
utilization of antioxidant combinations has shown more
promise (16).
Because to our knowledge no study has yet been pub-
lished that directly examines n-3 fatty acid supplementation
and direct markers of oxidative damage after exhaustive
exercise, the primary purpose of this project was to inves-
tigate whether supplementation would increase or decrease
F2-isoprostanes. F2-isoprostanes are bioactive compounds
that are considered to be the gold standard for determination
of oxidative stress. Interestingly, F2-isoprostanes are ele-
vated in obesity and various other disease states associated
with states of elevated oxidative stress (20). Second, we
wished to examine whether antioxidant vitamins might di-
rectly attenuate F2-isoprostanes when used as the only sup-
plement or reduce potential increases in F2-isoprostanes
associated with n-3fa peroxidation. We hypothesized that
n-3fa and antioxidant vitamins would reduce oxidative stress
and enhance antioxidant status.
METHODS
Subjects. Forty-eight trained cyclists were recruited
and randomized into vitamin–mineral (n = 12) (VM), n-3fa
(n = 11) (N3), vitamin and n-3fa combination (n = 13)
(VN3), or placebo (n = 12) (P) groups. Written informed
consent was obtained from each subject, and the experimen-
tal procedures were approved by the institutional review
board of Appalachian State University.
Research design. Before the start of supplementa-
tion, subjects reported to the University Human Perfor-
mance Laboratory for baseline orientation, blood sampling,
and measurement of cardiorespiratory fitness. V̇O2max was
determined using a graded maximal protocol (25 W in-
crease every 2 min starting at 150 W), with the subjects
using their own bicycles on CompuTraineri Pro Model
8001 trainers (RacerMate, Seattle, WA). Oxygen uptake
and ventilation were measured using the MedGraphics CPX
metabolic system (MedGraphics Corporation, St. Paul, MN).
HR was measured using a chest HR monitor (Polar Electro
Inc., Woodbury, NY). Basic demographic and training data
were obtained through a questionnaire. Body composition
was assessed by hydrostatic weighing using an electronic load
cell system (Exertech, Dresbach, MN), estimated residual
volume, and the Siri equation.
Subjects agreed to avoid the use of large-dose VM sup-
plements (above 100% of recommended dietary allowances),
herbs, and medications known to affect oxidative stress dur-
ing the entire study. During orientation, a dietitian instructed
the subjects to follow a diet moderate in carbohydrate (using
a food list) during the weekend before and 3 d of intensified
exercise period. At 12:00–12:30 p.m. before each 3-h cycling
bout, subjects ingested a standardized liquid meal (Boost
Plus; Mead Johnson Nutritionals, Evansville, IN) at an en-
ergy level of 63 kJIkgj1 (15 kcalIkgj1). Boost Plus is a
nutritionally complete, high-energy oral supplement with an
energy density of 6.4 kJImLj1 (1.52 kcalImLj1) and 16% of
energy as protein, 34% as fat, and 50% as carbohydrate. No
other food and beverage (other than water) was consumed
from this meal until the end of the cycling bout. Subjects
ingested 0.5–1 L of water per hour of cycling.
Supplementation. Subjects ingested the supplements
daily for 6 wk. Under double-blind procedures, subjects
assigned to placebo and n-3fa ingested four soft gel cap-
sules per day (two in the morning on an empty stomach at
7:00–8:00 a.m. and two at 6:00–8:00 p.m. before the
evening meal) for 6 wk before and during a 3-d period of
intensified exercise. The n-3fa capsules contained a high-
potency fish oil concentrate from anchovy and sardines,
with soybean oil, natural flavors, tocopherols, canola oil,
and citric acid, and provided 2000 mg of EPA and 400 mg
of DHA (in four soft gels). The placebo capsules were
identical in appearance and contained the same ingredients
but without the fish oil concentrate. The multivitamin–
mineral portion of the supplement contained a mixture of
vitamins and minerals with an emphasis on antioxidants
including vitamins C, E, and A. Subjects assigned to
vitamin and minerals ingested eight tablets per day (four
in the morning on an empty stomach at 7:00–8:00 a.m. and
four tablets at 6:00–8:00 p.m. before the evening meal)
for 6 wk before and during a 3-d period of intensified exer-
cise. A total of eight tablets provided vitamins C (2000 mg),
E (800 IU), and A (3000 IU) and selenium (200 Kg).
Subjects on combined n-3fa and vitamin and minerals took
a combination of two n-3fa softgels and four vitamin and
mineral tablets twice daily as described. To ensure com-
pliance, subjects were called weekly and e-mailed daily
for reminders and required to return the empty supplement
boxes.
Blood and exercise. Baseline blood samples (blood 1)
were collected between 7:30 and 9:00 a.m. after an over-
night fast and before supplement ingestion. Before exercise
and after 6 wk of supplementation, subjects provided blood
samples at 8:00 a.m. after an overnight fast and having
avoided exercise training for at least 12 h and before having
ingested the morning dose of supplements (blood 2). Sub-
jects then came back to the laboratory for three consecutive
days and cycled from 3:00 to 6:00 p.m. at approximately
57% maximal watts while continuing the daily supplement.
During the test sessions, experimental subjects cycled using
their own bicycles on CompuTraineri Pro Model 8001
trainers with the exercise load set at approximately 57%
maximal watts. Metabolic measurements were made every
30 min of cycling using the MedGraphics CPX metabolic
system to verify workload. Blood samples were obtained
within 15 min after completing the third 3-h exercise bout
(6:00 p.m.) (blood 3).
Blood sampling conditions and disposition. Blood
samples were drawn from an antecubital vein with subjects
in the supine position. A local clinical hematology labo-
ratory used a Coulter STKS instrument (Coulter Electron-
ics, Hialeah, FL) and provided hemoglobin and hematocrit
for determination of plasma volume change using the
method of Dill and Costill (9). Other blood samples were
centrifuged in sodium heparin or EDTA tubes, and plasma
was aliquoted and then stored at j80-C before analysis for
plasma EPA and DHA, F2-isoprostanes, and plasma anti-
oxidant parameters (ferric-reducing antioxidant potential
(FRAP) and oxygen radical absorption capacity (ORAC)).
F2-isoprostanes. Plasma F2-isoprostanes were de-
termined using gas chromatography mass spectrometry
(GC-MS) as previously described (21). Briefly, free F2-
isoprostanes were extracted from plasma added to a deu-
terated [2H4] PGF2 internal standard. The mixture was
then added to a C18 Sep Pak column, followed by silica
solid phase extractions. F2-isoprostanes were converted to
pentafluorobenzyl esters, subjected to thin layer chromatog-
raphy, and converted to trimethylsilyl ether derivatives.
Samples were analyzed by a negative ion chemical ioniza-
tion GC-MS using an Agilent 6890N gas chromatography
interfaced to an Agilent 5975B inert MSD mass spectrometer
(Agilent Technologies, Inc. Santa Clara, CA). Select ion
monitoring techniques were used to analyze the derivatives
of F2-isoprostanes and the internal standard. The height
of the two ions monitored (m/z 569 for F2-isoprostanes and
m/z 573 for the internal standard, respectively) were com-
pared to give a concentration of F2-isoprostane in plasma in
nanograms or picograms per milliliter.
Plasma EPA and DHA. After addition of 500 Kg of
butylated hydroxytoluene and 20 Kg of heptadecanoic acid
methyl ester (NU-Chek Prep, Inc. Elysian, MN) internal
standard to 100 KL thawed plasma, lipids were extracted,
and methyl esters were formed after the mixture was added
to 2 mL of methanolic 5% HCl and incubated at 80-C for
2 h in an OLS200 Shaking Waterbath (Grant Instruments
Ltd., Shepreth, Cambridgeshire, SG8 6 GB England). The
samples were cooled to room temperature upon completion
of the incubation, and the methyl esters were extracted
twice with 2 mL of n-hexane. The top layer of the super-
natant was combined and dried with N-EVAP116 Nitrogen
Evaporator (Organomation Associates, Inc. Berlin, MA).
The dried extract was then reconstituted in 200 KL of
n-hexane supplemented with 0.05% butylated hydroxy-
toluene, of which 1 KL was injected into an HP 6890N
gas chromatograph (Agilent Technologies, Palo Alto, CA)
equipped with a 5975B Inert XL MSD mass spectrometer
detector. A DB-WAX GC column (30 m  320 Km 
0.25 Km) from J &W Scientific (Agilent Technologies) was
used to separate the methyl esters of the extracted fatty acids.
Fatty acid concentrations were calculated in relation to the
heptadecanoic acid methyl ester internal standard peak. The
concentration of each phospholipid fatty acid was expressed
as a concentration (KgImLj1 plasma).
Ferric-reducing antioxidant potential. Total plasma
antioxidant potential was determined by the ferric-reducing
antioxidant potential (FRAP) assay according to the meth-
odology of Benzie and Strain (3). The basis of this assay is
that water-soluble reducing agents (antioxidants) in the
plasma will reduce ferric ions to ferrous ions, which then
react with an added chromogen. Samples and standards were
analyzed in duplicate and expressed as ascorbate equivalents
on the basis of an ascorbate standard curve (0–1000 Kmol).
Intraassay and interassay coefficients of variation were less
than 5% and 7%, respectively.
Oxygen radical absorption capacity (ORAC). The
ORAC assay was a modification of the methodology of
Ou et al. (24). Briefly, trolox standards were made from a
trolox stock solution. A serial dilution of a 50-Km trolox
solution was made with a phosphate-buffered solution to
produce 25, 12.5, and 6.25 Km of trolox standards. A fluo-
rescein (Sigma-Aldrich Chemicals, St. Louis, MO) working
solution was made by pipetting 800 KL of stock solution into
50 mL of phosphate buffer in a 50-mL conical tube. Before
use, the solution was incubated in the water bath at 37-C
until thoroughly heated.
The AAPH solution was made by dissolving 0.108 g of
AAPH (Wako Chemical, Richmond, VA) into 5 mL of
TABLE 1. Subject characteristics for baseline measures (values are presented as mean T SEM).
Variable P (n = 12) VM (n = 12) N3 (n = 11) VN3 (n = 13) P Value
Age (yr) 26.9 2.8 22.2 T 0.9 24.1 2.4 25.2 T 2.1 0.460
Body mass (kg) 67.4 3.8 73 T 3.5 68.9 3.0 66.7 T 4.0 0.761
V̇O2peak (mLIkg
j1Iminj1) 58.8 3.1 66.6 T 3.1 62.9 3.8 59.8 T 7.3 0.408
Powermax (W) 251 18.5 309 T 14.6 284 13.9 281 T 16.8 0.172
HRmax (beatsImin
j1) 185 2.8 187 T 2.2 188 3.0 187 T 3.0 0.362
Body composition (% fat) 16.4 2.7 14.5 T 1.8 13.7 1.8 14.8 T 1.7 0.431
BMI (kgImj2) 21.1 T 1.2 23.1 T 1.2 21.7 T 0.7 21.7 T 1.2 0.671
Training (kmIwkj1) 209 T 36.2 240 T 31.4 213 T 38.5 264 T 38.5 0.681
Training (hIdj1) 0.64 T 0.13 1.14 T 0.22 1.09 T 0.17 1.02 T 0.19 0.173
P, placebo; VM, vitamin–mineral; N3, n-3 fatty acid; VN3, vitamin–mineral and n-3 fatty acid combination.
incubated phosphate buffer immediately before the start
of the assay. The microplate was prepared and loaded in a
‘‘forward-then-reverse’’ order to avoid possible positional
errors. The edge wells were left empty or blank (phosphate-
buffered working solution) to reduce the impact of ‘‘edge
effect’’ on samples and standards particularly from tem-
perature effects on the outside wells. Twenty microliters of
sample, blank, and trolox standard solutions were pipetted
into appropriate wells. Then, 200 KL of fluorescein working
solution was added to each well using an eight-channel
micropipettor. A cover was placed on the microplate, and the
plate and the contents were incubated at 37-C for at least
20 min. Then, 20 KL of AAPH working solution was added
using an eight-channel micropipettor as quickly as possible.
Final ORAC values (KmILj1 trolox) were made from the
plate reader-derived area under the curve. Then, the final
ORACFL values were calculated by using a quadratic regres-
sion equation x = jb T ¾b2 j 4ac + 4cy. Excitation wave-
length was 485 nm, and emission wavelength was 520 nm.
Statistical analysis. Data are expressed as mean T
SEM. All data were screened for outliers with outliers desig-
nated as being outside of the mean T 2.5 SD. Data in Tables 1
and 2 were compared between groups using Student’s t-tests.
All other data (Figs. 1–5) were analyzed using a 4 (groups)
 3 (time points) repeated-measures ANOVA to determine
overall main effects. To account for multiple comparisons
between treatments, a Bonferroni adjustment was made and
the significant P value established as P e 0.017 and the data
compared using one-way ANOVA. These data analysis
allowed group comparisons for two different effects: 6 wk
of chronic supplementation and acute postexercise changes.
RESULTS
Descriptives. Subject baseline characteristics are sum-
marized in Table 1. Outcome data for male and female
cyclists did not differ significantly and are presented to-
gether for each group. During the 3-h cycling bouts, tem-
perature averaged 22.4-C T 0.06-C and relative humidity
35.8% T 1.6%. No significant differences were found
among groups for basic physical characteristics (Table 1).
Subject performance characteristics were averaged over the
three exercise sessions and are presented in Table 2. There
was no effect of treatment group on any exercise related
performance variable. Plasma volume change did not differ
between groups postexercise on the third day and averaged
less than 2% because of ingestion of 0.5–1.0 L of water
per hour of exercise (data not shown).
Oxidative, n-3fa, and antioxidant variables. EPA
and DHA supplementation resulted in drastic increases from
baseline to preexercise. DHA main effects were treatment
(P = 0.068), time (P = 0.004), and interaction (P = 0.006).
TABLE 2. Performance measures for average of three exercise sessions (values are presented as mean T SEM).
Variable P (n = 12) VM (n = 12) N3 (n = 11) VN3 (n = 13) P Value
Watts 143 T 10.3 175 T 8.5 162 T 8.1 160 T 9.9 0.102
Power (% Wmax) 56.8 T 0.2 56.7 T 0.3 56.8 T 0.2 57.1 T 0.2 0.822
Mean HR (beatsIminj1) 144 T 3.4 137 T 1.8 141 T 2.2 139 T 2.6 0.322
HR (% HRmax) 78.2 T 1.1 73.4 T 1.0 74.8 T 1.4 74.6 T 1.9 0.069
Mean V̇O2 (mLImin
j1) 2589 T 180 3025 T 153 2725 T 170 2846 T 193 0.590
V̇O2 (%V̇O2peak) 66.3 T 3.0 63.2 T 2.2 64.2 T 3.2 65.1 T 3.7 0.642
RPE (rating perceived exertion) 13.0 T 0.3 12.9 T 0.3 13.4 T 0.4 12.9 T 0.4 0.136
P, placebo; VM, vitamin–mineral; N3, n-3 fatty acid; VN3, vitamin–mineral and n-3 fatty acid combination.
FIGURE 1—Plasma DHA values over time among four treatments. Treatment effect (P = 0.184), time effect (P = 0.002), and treatment  time
interaction (P = 0.006). *P e 0.0125 after Bonferroni correction versus placebo value at baseline (n = 8). Values are presented as mean T SEM.
Plasma DHA increased 55.8% in N3 and 95.3% in VN3 from
baseline to preexercise, respectively (Fig. 1). EPA exhibited
significant treatment (P e 0.001), time (P e 0.001), and
interaction effects (P e 0.001). Plasma EPA increased 61.5%
in N3 and 778% in VN3 from baseline to preexercise
(Fig. 2). The change in F2-isoprostanes produced signifi-
cant overall treatment effects (P = 0.014) and time effects
(P = 0.001). Interestingly, F2-isoprostanes increased approx-
imately 53% from baseline to immediately postexercise in
N3. This change was significantly higher versus the change
observed in P (P e 0.01). VM and VN3 groups were not
different from P (Fig. 3). When specific comparisons of the
pattern of change in F2-isoprostanes from baseline to post-
exercise were made between treatments, F2-isoprostanes in
N3 were higher versus P (P = 0.020), higher versus VM
(P = 0.008), and higher versus VN3 (P = 0.05) (Fig. 3).
ORAC declined similarly and significantly among all
groups (P e 0.001) from preexercise, but the pattern of
change was not different between groups (P = 0.217). The
exercise-induced decline was greatest in P (37%) versus
N3 (23%), VM (23%), and VN 3 (21%) (Fig. 4). FRAP
plasma antioxidant capacity values were higher after ex-
ercise among all groups. However, only the vitamin and
mineral containing groups exhibited significant differences
from baseline (P e 0.017) after Bonferroni correction.
Overall effects for FRAP values were treatment (P = 0.300,
time (P = 0.003), and interaction (P = 0.045). FRAP in-
creased 26% immediately postexercise in VN 3, 19% in
VM, 5.9% in N3, and 9.5% in P (Fig. 5).
DISCUSSION
One of the most important outcomes of this investigation
was that consumption of a supplement containing 2000 mg
of EPA and 400 mg of DHA daily for 6 wk and during 3 d
of intense exercise resulted in a significantly larger increase
(53% increase from preexercise) in F2-isoprostanes compared
FIGURE 2—Plasma EPA values over time among four treatments. Treatment effect (P = 0.001), time effect (P = 0.001), and treatment  time
interaction (P = 0.001). *P e 0.0125 after Bonferroni correction versus placebo value at baseline (n = 9). Values are presented as mean T SEM.
FIGURE 3—F2-isoprostane values over time among four treatments. Treatment effect (P = 0.014), time effect (P = 0.002), and treatment  time
interaction (P = 0.224). *P e 0.0125 after Bonferroni correction versus placebo value at baseline (n = 12). Values are presented as mean T SEM.
with placebo and other antioxidant and n-3fa combinations
after exhaustive exercise. This is of some importance given
that F2-isoprostanes are bioactive and elevated in obesity
and various other disease states (20). This outcome supports
previous concerns that an increased ingestion of polyunsatu-
rated fatty acids, whether n-3fa or n-6fa , might lead to in-
creased lipid peroxidation (19). As further evidence that n-3fa
enhanced lipid peroxidation in our study, F2-isoprostanes
were only increased by 10% or less within the treatment
groups that did not contain n-3fa. These smaller changes in
F2-isoprostanes are similar to other studies we have con-
ducted, indicating that longer duration exercise (exceeding
1 h) does not increase F2-isoprostanes to the degree of
shorter intense exercise (17,23).
Several interesting points emerge from our investigation.
Although it is clear that increased n-3fa ingestion can result
in increased lipid peroxidation (11,29), the n-3fa peroxida-
tion products do not directly result in production of F2-
isoprostanes. Instead, the main products are F3-isoprostanes
(from EPA) and F4-isoprostanes (from DHA) (30) as well
as the aldehyde fragment 4-hydroxy-2E-hexenal (11). These
compounds have been found to be increased in tissues sub-
mitted to oxidative stress (11,30). As F2-isoprostanes derive
solely from the oxidation of arachidonate (20), this implies
that downstream n-3fa peroxidation products or some other
mechanism increases F2-isoprostanes indirectly. In support
of this hypothesis, Catala (6) states that lipid hydroper-
oxides can participate in chain reactions that increase dam-
age to other lipid biomolecules. Most hydroperoxides are
reduced to corresponding alcohols by glutathione perox-
idases but some degrade into other compounds, including
hydroxy-alkenals. The best known of these are 4-hydroxy-
2-nonenal (4-HNE) and 4-hydroxy-2E-hexenal, which
derive from lipid peroxidation of n-6fa and n-3fa, respec-
tively. These aldehydes are relatively stable and can diffuse
within or escape from the cell and attack other biomole-
cules distant from the original event. These aldehydes ex-
hibit great reactivity with proteins, DNA, and membrane
bound phospholipids. Arachidonic acid is prominent in mem-
brane phospholipids that would oxidize directly to produce
F2-isoprostanes (20).
Another observation is that n-3fa supplementation typi-
cally reduces baseline concentrations of F2-isoprostanes (19).
Nalsen et al. (22) found that supplementation with a total
of 3.6 g n-3fa (2.4g EPA and DHA combined) per day sig-
nificantly reduced F2-isoprostane concentrations in non-
exercising healthy humans after 3 months versus placebo.
Mori et al. (19) provided daily fish meals or EPA and DHA
FIGURE 4—Plasma ORAC values over time among four treatments. Treatment effect (P = 0.187), time effect (P = 0.001), and treatment  time
interaction (P = 0.381). *P e 0.0125 after Bonferroni correction versus placebo value at baseline (n = 10). Values are presented as mean T SEM.
FIGURE 5—FRAP values over time among four treatments. Treatment effect (P = 0.409), time effect (P = 0.002), and treatment  time interaction
(P = 0.035). *P e 0.0125 after Bonferroni correction versus placebo value at baseline (n = 12). Values are presented as mean T SEM.
and found that urinary F2-isoprostanes were significantly
reduced by 20%–27% in both trials. We did not observe this
decrease from baseline with 6 wk of supplementation. An
interesting difference is that our entire subject population
were athletes engaged in routine heavy endurance exercise
versus those of Mori et al. (19) and Nalsen et al. (22).
Because the concentration of F2-isoprostanes was so
drastically increased postexercise versus other treatments,
we hypothesize that consumption of high amounts of n-3fa
(14) does not increase peroxidation until a state of high
oxidative stress is initiated. Excessive radical formation
and trauma during exercise leads to an inflammatory state
that may propagate overall lipid peroxidation and increase
F2-isoprostanes as addressed earlier. Because n-3fa are
apparently susceptible to oxidation during exercise, it
becomes important whether the chain reaction of lipid per-
oxidation can be interrupted by increased dietary antiox-
idants and whether increased concentrations of n-3fa in
the cellular membrane increase antioxidant requirements.
F2-isoprostanes were increased 53% by n-3 fatty acids
alone but only 32.8% by the same amount of n-3fa coupled
with large-dose antioxidant vitamins. Interestingly, this
suggests that coingestion of antioxidants with the n-3fa
offered some protection from oxidation. Although using
a less sensitive indicator of lipid peroxidation, Allard et al.
(1) examined supplementation with a total of 6.26 g of
EPA and DHA n-3fa daily for 6 wk in 80 healthy men
alone or in combination with alpha-tocopherol (900 IU of
vitamin E) versus placebo on lipid peroxidation. Supple-
mentation with n-3fa significantly increased plasma MDA
and lipid peroxides. However, consumption of vitamin E
concurrent with the n-3fa did not reduce the increase in
lipid peroxidation. In contrast, we used combinations of
antioxidants added to the n-3fa supplement, which may
have been more effective and accounted for the attenuation
in F2-isoprostanes observed in the n-3 and antioxidant com-
bination group (16).
FRAP plasma antioxidant capacity values were higher
after exercise among all groups. However, only the vitamin
and mineral containing groups exhibited significant dif-
ferences from baseline. The FRAP assay has been found to
respond strongly to the presence of water-soluble antioxi-
dants such as urate and vitamin C (3). Interestingly, vitamin
and mineral supplementation did not significantly increase
ORAC value compared with placebo. Plasma ORAC values
declined significantly and similarly between treatments after
exercise, suggesting depletion of an antioxidant or multiple
antioxidants, which was not prevented by antioxidant
supplementation. The uniqueness of the ORAC assay is that
total antioxidant capacity of a sample is estimated by taking
an oxidation reaction to completion. ORAC measures all of
the nonprotein antioxidants, which include alpha-tocopherol,
glutathione, vitamin C, beta-carotene, uric acid, and biliru-
bin. In this regard, ORAC constitutes more of a compre-
hensive antioxidant measurement encompassing multiple
antioxidants.
Whether strenuous exercise greatly increases the need
for additional antioxidant vitamin and minerals in the diet
or through supplementation is not clear. Interestingly, the
opposite may be true because Gomez-Cabrera et al. (10)
and Ristow et al. (25) found that supplementation with
antioxidant vitamins actually reduced beneficial adapta-
tions from exercise and therefore might be contraindicated.
Nonetheless, as previously mentioned, we observed higher
FRAP values postexercise in the groups receiving vitamin and
minerals, but this did not affect F2-isoprostanes. However,
Mastaloudis et al. (16) found that 6 wk of supplementation
with 1000 mg vitamin C and 300 mg RRR-alpha-tocopheryl
acetate prevented exercise-induced F2-isoprostanes but had
no effect on inflammatory markers after a 50-km ultramar-
athon. McAnulty et al. (17) examined the effect of 2 months
of vitamin E supplementation (800 IUId of alpha-tocopherol)
in highly trained athletes during exhaustive exercise on plasma
antioxidant potential and F2-isoprostanes. Conversely, this
study found that prolonged large doses of alpha-tocopherol
supplementation did increase plasma antioxidant poten-
tial postexercise, but lipid peroxidation was actually higher
in the supplemented group versus placebo. Nieman et al.
(23) evaluated the influence of vitamin C supplementation
(1500 mgIdj1) during the 7-d period before the race and on
race day compared with placebo on F2-isoprostanes in run-
ners competing in an ultramarathon race. Despite higher
plasma vitamin C concentrations, no significant effects were
measured for lipid hydroperoxides or F2-isoprostanes. Evi-
dently, multiple factors such as timing, type and concen-
tration of antioxidants, and mode of exercise influence the
outcomes associated with antioxidant supplementation.
In conclusion, despite the beneficial effects typically asso-
ciated with n-3fa ingestion, we observe for the first time
evidence that supplementation with n-3fa is associated with
significantly increased F2-isoprostanes in response to heavy
cycling exercise. Supplementation with antioxidant vitamin
combinations and minerals did not significantly influence
F2-isoprostane formation versus placebo. Furthermore, n-3fa
supplementation did not influence any measure of plasma
antioxidant capacity, but a vitamin and mineral supplemen-
tation was effective at increasing FRAP values. On the basis
of our results, further assessment is clearly needed to exam-
ine whether the possible benefits of n-3fa supplementation
would outweigh the potential risks of increased lipid per-
oxidation in athletes who are engaged in heavy exercise.
Furthermore, because this study was conducted in a young fit
population, future studies should include aging or older
adults, whom often are prescribed exercise and fish oils to
promote cardiovascular health because aging compromises
antioxidant defenses (13).
This project was funded by the Cooper Aerobics Center, Dallas,
Texas.
The results of this study do not constitute endorsement by the
American College of Sports Medicine.
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